Speaker

Harshini Neelakantan

Executive Director - Research & Development, Ridgeline Therapeutics

Harshini Neelakantan, Executive Director - Research & Development at Ridgeline Therapeutics, is speaking at 3rd Obesity & Weight Loss Drug Development Summit West (San Diego, United States of America, 9–10 Dec 2026) in the session “Preserving Muscle Strength to Maximize the Impact of GLP-1s in Obesity Management”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

3rd Obesity & Weight Loss Drug Development Summit West
9–10 Dec 2026San Diego, United States of America
- SpeakerPreserving Muscle Strength to Maximize the Impact of GLP-1s in Obesity Management

More speakers at 3rd Obesity & Weight Loss Drug Development Summit West

Mini Balakrishnan
Vice President, Biology, Biomea Fusion
Jeremiah Bearss
Vice President - Clinical Development, Biolexis Therapeutics
Ashok Bhandari
Executive Vice President & Chief Discovery Officer, Protagonist Therapeutics
Patrick Griffin
Founder & CEO, Incregen Therapeutics
Charles Harris
Associate Vice President, Eli Lilly & Co.
Hans Keirstead
Chairman, Immunis

See all 11 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Harshini Neelakantan, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].